Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study

Autor: Myers, Andrea P., Filiaci, Virginia L., Zhang, Yuping, Pearl, Michael, Behbakht, Kian, Makker, Vicky, Hanjani, Parviz, Zweizig, Susan, Burke, James J., II, Downey, Gordon, Leslie, Kimberly K., Van Hummelen, Paul, Birrer, Michael J., Fleming, Gini F.
Zdroj: In Gynecologic Oncology April 2016 141(1):43-48
Databáze: ScienceDirect
Externí odkaz: